Roivant, Pfizer shares rise as Roche agrees to buy immunology company for $7.1 billion
October 23, 2023 at 08:36 AM EDT
'Transformative transaction' for Roivant gives Roche rights to promising inflammatory bowel disease treatment
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|